MPLTMapLight Therapeutics Inc.
Company Overview
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
P/E
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Interest & Investment Income
Other Income / (Expense), net
Total Other Income / (Expense), net
Earnings History
Estimated EPS
Reported EPS
N/ACompany Overview
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
P/E
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Interest & Investment Income
Other Income / (Expense), net
Total Other Income / (Expense), net
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
Company Info
CEO
Christopher A. Kroeger
Location
California, USA
Exchange
Nasdaq
Website
https://maplightrx.com/
Summary
We are a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders.
Company Info
CEO
Christopher A. Kroeger
Location
California, USA
Exchange
Nasdaq
Website
https://maplightrx.com/
Summary
We are a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders.
Be the first to know. We'll notify you when AI insights for MPLT go live.
Community Research
Research from investors like you
Be the first to share your analysis on MPLT
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Symbol's posts
No more topics to show